GC
Grimes & Company’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Hold |
2,784
| – | – | 0.01% | 383 |
|
|
2025
Q1 | $226K | Hold |
2,784
| – | – | 0.01% | 335 |
|
|
2024
Q4 | $251K | Buy |
2,784
+691
| +33% | +$62.2K | 0.01% | 334 |
|
|
2024
Q3 | $207K | Buy |
+2,093
| New | +$207K | 0.01% | 347 |
|
|
2024
Q1 | – | Sell |
-60,750
| Closed | -$5.42M | – | 357 |
|
|
2023
Q4 | $5.42M | Buy |
+60,750
| New | +$5.42M | 0.18% | 97 |
|
|
2018
Q4 | – | Sell |
-4,670
| Closed | -$448K | – | 249 |
|
|
2018
Q3 | $448K | Buy |
+4,670
| New | +$448K | 0.04% | 167 |
|